Skip to main content
Caplight Logo









Conexeu Sciences Inc.

Conexeu Sciences Inc.

Public

Conexeu Sciences Inc. is now publicly traded

The data on this page reflects Conexeu Sciences Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Oct 29, 2026

Total Funding Raised

$12.19M

Company Overview

Conexeu Sciences Inc. is based in RENO. It has raised $12.19M.

Conexeu Sciences Inc. is a biotechnology company that develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics, wound care, and tissue engineering.

AI Layer

Non-AI

Conexeu Sciences Inc. Comparables

Compare Conexeu Sciences Inc. with similar companies based on industry and business-model similarity.

Conexeu Sciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RegenX Science
79%
LifeSprout
77%
GenAssist, Inc.
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Conexeu Sciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementOct 29, 2026
Private PlacementOct 28, 2026
Private PlacementOct 15, 2026
Private PlacementSep 23, 2026
Seed RoundSep 1, 2026
Private Placement
Jul 23, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jeff Sharpe

Chief Executive Officer, Director

Executive Team

Miles Harrison

President Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Conexeu Sciences Inc. Investors

Notable investors and investment history

Conexeu Sciences Inc. investors
InvestorRounds
EquifundCrowdfunding
UBC Investment ManagementSeed

Recent news

Latest coverage and updates

  • is_developingAug 13, 2026

    Conexeu Sciences Inc. is developing its proprietary CXU(TM) platform, a preclinical-stage thermosensitive collagen-based extracellular matrix designed to support tissue regeneration across wound care, aesthetics, oral health, animal health, and 3D bioprinting.

Book a demo to see all news

For institutional investors. Book with your work email.

Conexeu Sciences Inc. Filings

Explore SEC and related filing metadata, where available.

Conexeu Sciences Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersRENO
Employee Range12
Year Founded2022
Last FundingOct 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?